Table 2.
Prevalence of West Nile Virus IgM, Dengue Virus IgM, and Flavivirus IgG in Each Study Group
|
Study group |
||
---|---|---|---|
Serologic test | Blood donors | Febrile patients | Encephalitic patients |
WNV MAC-ELISA | 0/800 (0%) | 0/588 (0%) | 0/44 (0%) |
DENV MAC-ELISA | 16/800 (2.0%) | 44/588 (7.5%) | 0/44 (0%) |
Flavivirus IgG ELISA | 80/135 (59.3%) | 142/248 (57.3%) | 17/42 (40.5%) |
Data are presented as the number of individuals tested/number of individuals positive.
WNV MAC-ELISA, West Nile virus IgM antibody-capture enzyme-linked immunosorbent assay; DENV MAC-ELISA, dengue virus IgM antibody-capture enzyme-linked immunosorbent assay.